Methylnaltrexone Bromide

Records for this ingredient, by country (identity only).

ATC A06AH01 · 4 markets · 4 records

Methylnaltrexone Bromide 4 markets · 4 records Forms
Filters

AU 1 records · 1 shown of 1 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

  • 12 mg per mL / per unit basis not statedinjectionRELISTOR methylnaltrexone bromide 12 mg/0.6 mL solution for injection vial unknown

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

  • 12 mg/0.6 mLinjectionRelistor Solution For Injection 12mg/0.6mL also in FR

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 12 mg/0.6 mLinjectionRELISTOR 12 mg/0,6 ml, solution injectable also in SG

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.